Latest Capital Raising News

RLF AgTech has posted its strongest trading period with $18.3 million revenue year-to-date and positive EBITDA in March, driven by a strategic reset under new CEO Stuart Upton and a $4.5 million capital raise.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

DevEx Resources is gearing up for a major uranium drilling campaign in 2026 after expanding its Northern Territory footprint and securing nearly $39 million in fresh capital. Soil anomalies at Murphy West and strategic licence acquisitions set the stage for exploration in the McArthur Basin.

Santana Minerals advanced its Bendigo-Ophir Gold Project in New Zealand with a confirmed consent decision date, major equipment agreements, and a substantial capital raise, setting the stage for development.

Icetana AI reported a 51% year-on-year jump in annual recurring revenue to $2.6 million but faced a $1.2 million net operating cash outflow in Q3 FY26, prompting plans for a capital raise amid expected cash flow improvements.

AuKing Mining has bolstered its project portfolio with the acquisition of a Tasmanian tin and silver licence and the Malawi-based Tundulu Rare Earths Project, supported by $5 million in recent equity placements.

Celsius Resources has revealed it was not informed before Maharlika Investment Corporation assigned its loan under the Omnibus Loan and Security Agreement with Makilala Mining to an Indian firm, prompting legal and financial review.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

Sabre Resources (ASX:SBR) has secured 80% stakes in two companies holding nearly 4,000km² of highly prospective gold and copper-gold projects in the Northern Territory, including drill-ready targets analogous to the Tennant Creek Mineral Field. A heavily supported $2 million placement will fund aggressive exploration including imminent drilling.

Anagenics Limited delivered a third quarter operational performance aligned with budget following its restructuring, with cash outflows narrowing and its Bouf Haircare brand generating robust royalty revenue.

Kuniko Limited has launched a prospectus offering over 51 million new options following a $3.75 million share placement, aiming to facilitate secondary trading and potential future capital raising through option exercises.

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.